The Safety and Efficacy of an Oral Superfruits Supplement

NCT ID: NCT05694182

Last Updated: 2025-03-28

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

15 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-12-01

Study Completion Date

2023-12-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study is conducted to evaluate the safety and effectiveness of an oral superfruits supplement for skin brightening and wrinkle reduction. Superfruits are reported to have high bioactive compounds with beneficial effects on human health. The study duration is 12 weeks and the skin assessment will be carried out at baseline, week 2, week 6 and week 12. The participants will consume the supplement for 6 weeks and at week 12, final skin assessment will be conducted. The main questions this study aims to answer are:

1. The skin brightening effect of the oral superfruits supplement.
2. The effect of the oral superfruits supplement on wrinkle reduction.
3. To observe any adverse effect occurrence with the consumption of the oral superfruits supplement.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Healthy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

OTHER

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Oral superfruits supplement

Participants will consume oral superfruits supplement once daily for 6 weeks.

Group Type EXPERIMENTAL

Other: Oral superfruits supplement

Intervention Type OTHER

The supplement contain superfruits that are beneficial for human health

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Other: Oral superfruits supplement

The supplement contain superfruits that are beneficial for human health

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Malaysian citizen
* Male and female (age 20-60 years old)

Exclusion Criteria

* Participant who taking any dietary supplements for the past 4 weeks which can affect the study results
* Participant who are on contraceptive pills for the past 3 months
* Participant who undergo cosmetics treatments such as botox, filler and laser and light treatment within the last 3 months
* Pregnant or plans to get pregnant and breastfeeding women
Minimum Eligible Age

20 Years

Maximum Eligible Age

60 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Ungku Shahrin Medical Aesthetic Research & Innovation (USMARI) Centre

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Ungku Shahrin Medical Aesthetic Research & Innovation (USMARI) Centre

Petaling Jaya, Selangor, Malaysia

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Malaysia

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

UMRAMREC003-22

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

The Effect of Lipmatte K
NCT05694442 COMPLETED NA